128 related articles for article (PubMed ID: 29696960)
1. Reversible splenial lesion in neuroleptic malignant syndrome.
Gasparini A; Poloni N; Caselli I; Ielmini M; Callegari C
Panminerva Med; 2018 Sep; 60(3):134-135. PubMed ID: 29696960
[No Abstract] [Full Text] [Related]
2. Clinically mild encephalopathy with a reversible splenial lesion and nonconvulsive status epilepticus in a schizophrenic patient with neuroleptic malignant syndrome.
Mogi T; Toda H; Tatsuzawa Y; Fukutomi T; Soga S; Shinmoto H; Yoshino A
Psychiatry Clin Neurosci; 2017 Mar; 71(3):212. PubMed ID: 27976828
[No Abstract] [Full Text] [Related]
3. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.
Kaino K; Kumagai R; Furukawa S; Isono M; Muramatsu A; Fujii M; Muta Y; Asada T; Fujihara K; Yagyu H
J Diabetes Investig; 2017 May; 8(3):392-394. PubMed ID: 27863115
[TBL] [Abstract][Full Text] [Related]
4. A Reversible Isolated Lesion in the Splenium of Corpus Callosum in a Patient with Probable Neuroleptic Malignant Syndrome -- Case Report.
Yeh CT; Fu CH
Acta Neurol Taiwan; 2015 Sep; 24(3)():87-91. PubMed ID: 27333832
[TBL] [Abstract][Full Text] [Related]
5. [Syndrome of mild encephalopathy with a reversible splenial corpus callosum lesion].
Titov AV; Novicova VS; Ochkin SS; Soloveva EY
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):85-87. PubMed ID: 29376989
[TBL] [Abstract][Full Text] [Related]
6. Reversible abnormality of the splenium in a bipolar patient with neuroleptic malignant syndrome.
Achalia R; Andrade C
Bipolar Disord; 2014 Nov; 16(7):773-5. PubMed ID: 24330276
[TBL] [Abstract][Full Text] [Related]
7. Lithium induced reversible Splenial lesion in neuroleptic malignant syndrome like symptoms: two case reports.
Ryu HU; Chung JY; Shin BS; Kang HG
BMC Neurol; 2020 Apr; 20(1):164. PubMed ID: 32354328
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Magnetic Resonance Imaging Features of Reversible Splenial Lesion Syndrome in Adults: A Small Case Series.
Xu W; Zhou Y; Jiang Y; Zhang L; Tang Q
Eur Neurol; 2019; 82(4-6):86-92. PubMed ID: 31927555
[TBL] [Abstract][Full Text] [Related]
9. Reversible Splenial Lesion Syndrome as a Challenging Casuistry.
Tatar D; Bocian B; Świerzy K; Badura Brzoza K
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011475
[TBL] [Abstract][Full Text] [Related]
10. Reversible Splenial Lesion Syndrome (RESLES) Following Glufosinate Ammonium Poisoning.
Jeong TO; Yoon JC; Lee JB; Jin YH; Hwang SB
J Neuroimaging; 2015; 25(6):1050-2. PubMed ID: 25682793
[TBL] [Abstract][Full Text] [Related]
11. Cerebral infarction in neuroleptic malignant syndrome.
Pullicino P; Galizia AC; Azzopardi C
J Neuropsychiatry Clin Neurosci; 1991; 3(1):75-7. PubMed ID: 7580178
[TBL] [Abstract][Full Text] [Related]
12. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).
Takanashi J; Imamura A; Hayakawa F; Terada H
J Neurol Sci; 2010 May; 292(1-2):24-7. PubMed ID: 20236662
[TBL] [Abstract][Full Text] [Related]
13. Iatrogenic encephalopathy or reversible splenial lesion syndrome (RESLES)?
Cerimagic D
Clin Neurol Neurosurg; 2023 Dec; 235():108046. PubMed ID: 37949040
[No Abstract] [Full Text] [Related]
14. Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review.
Jing C; Sun L; Wang Z; Chu C; Lin W
J Int Med Res; 2018 Mar; 46(3):1277-1281. PubMed ID: 29322880
[TBL] [Abstract][Full Text] [Related]
15. A splenial lesion with transiently reduced diffusion in clinically mild encephalitis is not always reversible: A case report.
Hashimoto Y; Takanashi J; Kaiho K; Fujii K; Okubo T; Ota S; Kohno Y
Brain Dev; 2009 Oct; 31(9):710-2. PubMed ID: 19046838
[TBL] [Abstract][Full Text] [Related]
16. A Rare Case Report of a Corpus Callosal Splenial Lesion in the Context of Atypical Neuroleptic Malignant Syndrome.
Serdenes R; Orr S; Trio P; Chandrasekhara S; Musselman M
J Investig Med High Impact Case Rep; 2021; 9():23247096211029751. PubMed ID: 34229456
[TBL] [Abstract][Full Text] [Related]
17. Marked elevation of urinary β2-microglobulin in patients with reversible splenial lesions: A small case series.
Azuma J; Nabatame S; Katsura T; Yamamoto K; Kaneno H; Kijima E; Mizoguchi Y; Shimotsuji T; Yamamoto T; Ozono K
J Neurol Sci; 2016 Sep; 368():109-12. PubMed ID: 27538611
[TBL] [Abstract][Full Text] [Related]
18. Reversible splenial lesion syndrome associated with dengue fever: a case report.
Sathananthasarma P; Weeratunga PN; Chang T
BMC Res Notes; 2018 Jun; 11(1):412. PubMed ID: 29945676
[TBL] [Abstract][Full Text] [Related]
19. Agraphia with reversible splenial corpus callosum lesion caused by hypoglycemia.
Miyakawa Y; Fuchigami T; Aoki M; Mine Y; Suzuki J; Urakami T; Takahashi S
Brain Dev; 2018 Aug; 40(7):592-595. PubMed ID: 29606344
[TBL] [Abstract][Full Text] [Related]
20. Reversible splenial lesion syndrome.
Elseed M; Baheerathan A; Kearney H; Abkur T
Br J Hosp Med (Lond); 2019 Dec; 80(12):734-735. PubMed ID: 31822180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
